AM-4030
AM-4030 is a synthetic cannabinoid that was developed for research purposes. It is structurally related to other cannabinoids and has been studied for its potential effects on the endocannabinoid system.
Chemical Structure[edit | edit source]
AM-4030 belongs to a class of compounds known as cannabinoids, which interact with the cannabinoid receptors in the brain and body. The chemical structure of AM-4030 includes a dibenzo[b,d]pyran ring system, which is a common feature in many synthetic cannabinoids.
Pharmacology[edit | edit source]
AM-4030 acts as an agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including pain, mood, and appetite.
Research and Applications[edit | edit source]
Research on AM-4030 has primarily focused on its interaction with the endocannabinoid system and its potential therapeutic applications. Studies have investigated its effects on pain management, neuroprotection, and anti-inflammatory properties.
Legal Status[edit | edit source]
The legal status of AM-4030 varies by country. In some jurisdictions, it may be classified as a controlled substance due to its potential for abuse and psychoactive effects.
See Also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD